News from neurocrine biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 20, 2015, 08:00 ET

Neurocrine Biosciences Announces Oral Presentation of NBI-77860 Clinical Trial Data in Classic Congenital Adrenal Hyperplasia at ENDO 2015

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the steering committee of ENDO 2015 has selected the abstract of their recently...

Jan 16, 2015, 14:30 ET

Neurocrine Biosciences Announces Granting of Orphan Drug Status for NBI-77860 in Congenital Adrenal Hyperplasia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor...

Jan 08, 2015, 13:00 ET

Neurocrine Biosciences to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will...

Dec 10, 2014, 08:00 ET

Neurocrine Biosciences Announces Expansion of its Clinical Pipeline

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-77860, a proprietary corticotropin releasing factor 1 (CRF) receptor...

Dec 04, 2014, 19:00 ET

Neurocrine Biosciences to Present at the 25th Annual Oppenheimer Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Nov 25, 2014, 13:00 ET

Neurocrine to Present at the 2014 Deutsche Bank BioFEST and the 26th Annual Piper Jaffray Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Nov 12, 2014, 13:56 ET

Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences,...

Nov 04, 2014, 07:30 ET

Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that Darin Lippoldt has joined the executive management team as Chief Legal...

Nov 03, 2014, 19:00 ET

Neurocrine Biosciences to Present at the Nomura Biotechnology Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Nov 03, 2014, 16:01 ET

Neurocrine Biosciences Reports Third Quarter 2014 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended September 30, 2014.  For the third...

Oct 30, 2014, 07:30 ET

Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy...

Oct 27, 2014, 16:05 ET

Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2014 financial results after the Nasdaq...

Oct 20, 2014, 16:05 ET

Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854

 Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a Phase III clinical trial (Kinect 3 Study) of its...

Oct 02, 2014, 16:02 ET

Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a clinical trial of NBI-98854, a proprietary small molecule...

Oct 01, 2014, 17:20 ET

Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Malcolm Lloyd-Smith has joined the executive management team as Chief Regulatory...

Sep 03, 2014, 13:00 ET

Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...

Aug 06, 2014, 16:02 ET

Neurocrine Biosciences Reports Second Quarter 2014 Results

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2014.  For the second quarter...

Jul 29, 2014, 10:00 ET

Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2014 financial results...

Jun 11, 2014, 07:00 ET

Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress

 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that on June 11, 2014, two scientific posters associated with its study of...

May 29, 2014, 13:00 ET

Neurocrine Biosciences To Present At The Jefferies 2014 Global Healthcare Conference

 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine...